Andros Pharmaceuticals Co.,Ltd Stock

Equities

6917

TW0006917008

Pharmaceuticals

End-of-day quote Taipei Exchange 18:00:00 2024-06-24 EDT 5-day change 1st Jan Change
20.25 TWD -0.49% Intraday chart for Andros Pharmaceuticals Co.,Ltd -0.74% -18.67%
Dynamic Chart
1 day-0.49%
1 week-0.74%
Current month-3.34%
1 month-4.93%
3 months-6.68%
6 months-18.84%
Current year-18.67%
More quotes
1 week
19.80
Extreme 19.8
20.65
1 month
19.80
Extreme 19.8
21.35
Current year
19.80
Extreme 19.8
26.60
1 year
19.80
Extreme 19.8
39.15
3 years
19.80
Extreme 19.8
46.30
5 years
19.80
Extreme 19.8
46.30
10 years
19.80
Extreme 19.8
46.30
More quotes
Managers TitleAgeSince
Chief Executive Officer - 08-06-30
Chief Operating Officer - -
More insiders
Date Price Change Volume
24-06-25 20.25 -0.49% 28,051
24-06-24 20.35 +0.25% 35,753
24-06-21 20.3 0.00% 37,633
24-06-20 20.3 -0.98% 79,859
24-06-19 20.5 +0.99% 48,549

End-of-day quote Taipei Exchange, June 24, 2024

More quotes
Andros Pharmaceuticals Co Ltd is a Taiwan-based company mainly engaged in the research, design, development, manufacture and sales of novel drug delivery systems and liposome formulation-related products. The products are focused on topical drugs and are developed with a focus on pain-related indications. The Company is mainly engaged in the authorization of product technology transfer, as well as the manufacture and sales of niche generic drugs and high-end skin care products. Niche generic drugs and high-end skin care products include LALP Cream, which is used for anesthesia before minor skin surgery and laser treatment; iMinos Solution, which is used for the treatment of androgenetic alopecia; and deoxyribonucleic acid (DNA) repair enzyme liposome (LipoT4N5), which has anti-wrinkle, anti-sun and anti-aging effects. The products are mainly sold in Hong Kong and Taiwan.
More about the company